Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
A.2.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.600SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.12 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.525 (Eta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
AY.6 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.5.5 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
P.1.7 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.24 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
B.1.1.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.39.1.3 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.1.3.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BA.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XBC.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Q.2 (Alpha)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BL.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
M.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.5.6 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.1.440SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.23.2 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.104 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.198SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-15597.1Singapore
XAFSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BC.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
P.1.17.1 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.177.41SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.375SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BL.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.75.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBHSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BL.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.78SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.9.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.64SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBC.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.221.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
DP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BL.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.1.177.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.82SYoung-STATACATGTCTCTGGGACCA20452176321782F-18860.4Singapore
XBB.1.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.38.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.79.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used